These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10937286)
61. Enhanced antioxidation via encapsulation of isooctyl p-methoxycinnamate with sodium deoxycholate-mediated liposome endocytosis. Zhang Y; Shen L; Zhang K; Guo T; Zhao J; Li N; Feng N Int J Pharm; 2015 Dec; 496(2):392-400. PubMed ID: 26453790 [TBL] [Abstract][Full Text] [Related]
62. Increased liposome extravasation in selected tissues: effect of substance P. Rosenecker J; Zhang W; Hong K; Lausier J; Geppetti P; Yoshihara S; Papahadjopoulos D; Nadel JA Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7236-41. PubMed ID: 8692975 [TBL] [Abstract][Full Text] [Related]
63. Enhanced efficacy of anti-miR-191 delivery through stearylamine liposome formulation for the treatment of breast cancer cells. Sharma S; Rajendran V; Kulshreshtha R; Ghosh PC Int J Pharm; 2017 Sep; 530(1-2):387-400. PubMed ID: 28774852 [TBL] [Abstract][Full Text] [Related]
64. Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance. Lee S; Lee J; Choi YW Biol Pharm Bull; 2007 Feb; 30(2):393-6. PubMed ID: 17268089 [TBL] [Abstract][Full Text] [Related]
65. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. Masini V; Bonte F; Meybeck A; Wepierre J J Pharm Sci; 1993 Jan; 82(1):17-21. PubMed ID: 8429486 [TBL] [Abstract][Full Text] [Related]
66. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. El Maghraby GM; Williams AC; Barry BW Int J Pharm; 2000 Aug; 204(1-2):159-69. PubMed ID: 11012000 [TBL] [Abstract][Full Text] [Related]
67. Skin oxygenation after topical application of liposome-entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size. Kristl J; Abramović Z; Sentjurc M AAPS PharmSci; 2003; 5(1):E2. PubMed ID: 12713274 [TBL] [Abstract][Full Text] [Related]
68. Liposome preparations: a step forward in topical drug therapy for skin disease? A review. Schäfer-Korting M; Korting HC; Braun-Falco O J Am Acad Dermatol; 1989 Dec; 21(6):1271-5. PubMed ID: 2685061 [TBL] [Abstract][Full Text] [Related]
69. Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo. He K; Liu J; Gao Y; Hao Y; Yang X; Huang G AAPS PharmSciTech; 2020 Jul; 21(5):193. PubMed ID: 32661922 [TBL] [Abstract][Full Text] [Related]
70. Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1954-6. PubMed ID: 7954945 [TBL] [Abstract][Full Text] [Related]
71. Lipid multilayer microarrays for in vitro liposomal drug delivery and screening. Kusi-Appiah AE; Vafai N; Cranfill PJ; Davidson MW; Lenhert S Biomaterials; 2012 Jun; 33(16):4187-94. PubMed ID: 22391265 [TBL] [Abstract][Full Text] [Related]
72. Enhanced delivery of retinoic acid to skin by cationic liposomes. Kitagawa S; Kasamaki M Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):242-4. PubMed ID: 16462074 [TBL] [Abstract][Full Text] [Related]
73. High-entrapment liposomes for 6-Mercaptopurine--a prodrug approach. Taneja D; Namdeo A; Mishra PR; Khopade AJ; Jain NK Drug Dev Ind Pharm; 2000 Dec; 26(12):1315-9. PubMed ID: 11147134 [TBL] [Abstract][Full Text] [Related]
74. Possibility and effectiveness of drug delivery to skin by needle-free injector. Inoue N; Todo H; Iidaka D; Tokudome Y; Hashimoto F; Kishino T; Sugibayashi K Int J Pharm; 2010 May; 391(1-2):65-72. PubMed ID: 20170719 [TBL] [Abstract][Full Text] [Related]
75. Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide. Fatouros DG; Antimisiaris SG J Drug Target; 2001; 9(1):61-74. PubMed ID: 11378524 [TBL] [Abstract][Full Text] [Related]
76. Characterization of distribution behavior of 2-imidazolines into multilamellar liposomes. Choi YW; Rogers JA J Pharm Sci; 1991 Aug; 80(8):757-60. PubMed ID: 1791536 [TBL] [Abstract][Full Text] [Related]
77. Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung. Zhao J; Qin L; Song R; Su J; Yuan Y; Zhang X; Mao S Eur J Pharm Biopharm; 2022 Mar; 172():101-111. PubMed ID: 35149189 [TBL] [Abstract][Full Text] [Related]
78. Liposome-mediated drug targeting in topical and regional therapies. Margalit R Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):233-61. PubMed ID: 9501970 [TBL] [Abstract][Full Text] [Related]
79. Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assay. Jacobs M; Martin GP; Marriott C J Pharm Pharmacol; 1988 Dec; 40(12):829-33. PubMed ID: 2907573 [TBL] [Abstract][Full Text] [Related]
80. Species difference in correlation between in vivo/in vitro liposome-complement interactions. Huong TM; Ishida T; Harashima H; Kiwada H Biol Pharm Bull; 2001 Apr; 24(4):439-41. PubMed ID: 11305612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]